Molecularly imprinted polymers and bio-engineering

Jun 08, 2012
Molecularly imprinted polymers and bio-engineering
Credit: Thinkstock

Biorecognition at the molecular level is a rapidly advancing technology that has enlisted the help of synthetic polypeptides to come up with the ultimate antibody.

The EU 'Synthetic superantibodies - Bioinspired engineering of artificial receptor structures' (Superantibodies) project merged two fundamental processes. Together, they have resulted in the development of synthetic receptors that favour selected biomolecular interactions such as antibody-antigen binding.

Combining materials science with has the potential to inject the wonders of unparalled biorecognition into non-biological materials. Generation of artificial affinity reagents with similar characteristics to antibodies would have a high degree of specificity and affinity with huge potential in the biotechnology field.

Although can be generated against almost any substance using the hybridoma technique, they are large, complex proteins with complicated recombinant expression necessary for their function. Furthermore, their products tend to be unstable. The Superantibodies team aimed to overcome all these obstacles with the added benefit of being cheap to produce.

The theory was to use a genetically manipulated protein with natural ligand-binding properties. Add to this fully synthetic affinity reagents that can be prepared inexpensively as well as offer stability, and the result is the new class of artificial recognition elements, molecularly imprinted polymers (MIPs).

Superantibodies has successfully produced a biohybrid. An site composed of synthetic polypeptide loops that interact cooperatively with the antigen is combined and used to produce templates. This model gives rise to a molecular imprinting process to produce site-specific peptides that can be integrated into the backbone of a MIP.

In theory, it will be possible to change the number and type of peptide to tailor recognition agents that will outperform naturally derived antibodies. Applications of this exciting new technology not only include antibody/antigen uses but can be extended to enzymes, nucleic acid interactions and biosensing generally.

Explore further: Don't lose the organism in the excitement over its genes, biologists urge

add to favorites email to friend print save as pdf

Related Stories

Manmade antibodies hold biomedical promise (w/ Video)

May 19, 2010

Antibodies are the immune system's warriors. Their role is to pinpoint disease pathogens, attaching to them and neutralizing their effects. Though antibodies are of great value for biomedical research, the process of creating ...

Researchers design Alzheimer's antibodies

Dec 09, 2011

Researchers at Rensselaer Polytechnic Institute have developed a new method to design antibodies aimed at combating disease. The surprisingly simple process was used to make antibodies that neutralize the ...

Recommended for you

'Whodunnit' of Irish potato famine solved

20 hours ago

An international team of scientists reveals that a unique strain of potato blight they call HERB-1 triggered the Irish potato famine of the mid-19th century.

Engineered microbes grow in the dark

May 20, 2013

Scientists at the University of California, Davis have engineered a strain of photosynthetic cyanobacteria to grow without the need for light. They report their findings today at the 113th General Meeting of the American ...

User comments : 0

More news stories

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Power of US tornado dwarfs Hiroshima bomb

Wind, humidity and rainfall combined precisely to create Monday's massive killer tornado in Oklahoma. The awesome amount of energy released dwarfed the power of the atomic bomb that leveled Hiroshima.